key: cord-0988124-9hgkc7d7 authors: de Castilho, Lia Silva; Lages, Frederico dos Santos; Ferreira, Rauel Victor Dutra; de Oliveira, Ana Cristina Borges; Vilaça, Ênio Lacerda; Diniz, Ivana Márcia Alves title: Breathing problems and COVID‐19 in patients with developmental disabilities date: 2020-08-03 journal: Spec Care Dentist DOI: 10.1111/scd.12504 sha: 0da06234addc4ee1997dbc0aeba908c3fe4a750c doc_id: 988124 cord_uid: 9hgkc7d7 nan induced bronchial hyperreactivity or eosinophilic inflammation. However, the nebulization was shown to increase the risk of viral deposition in the lower lung. In the face of uncharted territory and unprecedented times, there is a lot much to be learned about the impact of pediatric asthma in the course of infection with the SARS-CoV-2 virus. 4 Poor access to health care can be detrimental to pediatric health, and children with special needs are potentially at higher risk for severe diseases. Accordingly, developing countries such as Brazil are suffering even more with the SARS-CoV-2 outbreak. The epidemy has exponentially advanced overall the country. The official numbers are underestimated, challenging any further politics to prevent virus dissemination, that is, contingency plans and scientific studies. In the dental community, doubts about the outbreak have led to an array of professional concerns in terms of patient care provisions and safety measures. Until June 2020, there is no vaccine available for COVID-19, although several research groups have formulations in the testing phase. By now, a consensus about the guidelines applicable for special care management in the dental clinical setting remains unclear. We hypothesize that the prevalence of preexisting breathing problems in the population with developmental disabilities may serve as a predictor of possible complications in cases of infection with the new coronavirus. From our point of view, the implementation of new and stricter biosafety protocols is needed. The dental team, patients, and caregivers need to be constantly aware of the appearance of common COVID-19 symptoms, begin self-isolation, and avoid virus dissemination. Moreover, it is also possible to consider implementing preadmission or preprocedure testing for COVID-19, depending on testing availability and how rapidly the results are delivered. Despite that, there are limitations on this approach, like negative results from patients or professionals during the SARS-CoV-2 incubation period, who could become a transmission source later after testing. Moreover, individuals can be exposed or contribute to cross-contamination even by taking public transportation or while going to the supermarket. Accordingly, the gap between the moment Spec Care Dentist. 2020;1-2. wileyonlinelibrary.com/journal/scd 1 of testing until the results are delivered or the patient is admitted will always be an uncovered risky period. We believe that minimize elective treatments as far as possible are essential to reduce the exposure risk of special care patients while the pandemic exists. Otherwise, if necessary, elective treatments should be performed preferably in individuals who do not have any preexisting respiratory conditions. A second precaution, when available, would be the IgG and IgM anti-SARS-CoV-2 serology, even though it is still unknown whether these patients are immune and for how long. Finally, the dental team should be prepared for dental emergent/urgent situations, and remote support should always be offered to patients and caregivers whenever requested. Clinical and virological data of the first cases of COVID-19 in Europe: a case series National Health Commission & National Administration of Traditional Chinese Medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7) Factors associated with illness in children and young adults with cerebral palsy Managing asthma during COVID-19: an example for other chronic conditions in children and adolescents Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19